Presentations and References
Presentations
2007
R McFarland, E Lipscomb, D Allen, J Truax, R Tice, and W Stokes.
NICEATM and ICCVAM evaluation of five in vitro test methods for assessing
potential pyrogenicity of pharmaceuticals and other products. Sixth World Congress on
Alternatives and Animal Use in the Life Sciences. View
Poster.
References
G Duff, E Atkins. 1982. The detection of endotoxin by in vitro production of endogenous
pyrogen: comparison with amebocyte lysate gelation. J Immunol Methods 52: 323-331.
E Hansen, J Christensen. 1990. Comparison of cultured human mononuclear cells,
Limulus amebocyte lysate and rabbits in the detection of pyrogens. J Clin Pharm Ther. 15: 425-433.
T Hartung, I Aaberge, S Berthold et al. 2001. Novel pyrogen tests based on the human fever reaction.
Altern Lab Anim 29: 99-123.
S Hoffmann, A Pertbauer, S Schindler et al. 2005. International validation of novel pyrogen tests
based on human monocytoid cell lines. J Immunol Meth 298:161-173.
M Jahnke, M Weigand, H-G Sonntag. 2000. Comparative testing for pyrogens in parenteral drugs
using the human whole blood pyrogen test, the rabbit in vivo pyrogen test and the LAL test.
European Journal of Parenteral Science 5(2):39-44.
E Pool, G Johaar, S James, I Petersen, P Bouic. 1999. Differentiation between endotoxin and non-endotoxin
pyrogens in human albumin solutions using an ex vivo whole blood culture assay.
J Immunoassay 20:79-89.
I Spreitzer, M Fischer, K Hartzsch, U Luederitz-Pueschel, T Montag. 2000. Comparative study of
rabbit pyrogen test and human whole blood assay on human serum albumin.
ALTEX 19. Suppl. 1:73-75.
|
